|
| Section 1. Product and Company Identification |
| Product Name | OPD Tablets | Product Code | 6534 |
|
|
|
|
| For More Information Call | In Case of Emergency Call |
| 856-423-6300 Technical Service
Monday-Friday: 8:00 AM - 5:00 PM |
800-424-9300 CHEMTREC (USA)
613-996-6666 CANUTEC (Canada) 24 Hours/Day: 7 Days/Week |
| Synonym | None. |
| Material Uses | Analytical reagent.
|
| Chemical Family | mixture |
| Section 2. Composition and Information on Ingredients |
| Component | CAS # | % by Weight |
| L(+) Tartaric Acid | 87-69-4 | 12-18 |
| Sodium Cyclamate | 139-05-9 | 50-60 |
| L-Leucine | 61-90-5 | 1-4 |
| 1,2-Phenylenediamine Dihydrochloride | 615-28-1 | 6-10 |
| Sodium Carbonate, Anhydrous | 497-19-8 | 10-15 |
| Section 3. Hazards Identification |
| Physical State and Appearance | Solid. (Tablet) |
| Emergency Overview | DANGER!
HARMFUL IF INHALED, ABSORBED THROUGH SKIN OR SWALLOWED. CONTAINS MATERIAL WHICH MAY CAUSE CANCER BASED ON ANIMAL DATA. CAUSES RESPIRATORY TRACT, EYE AND SKIN IRRITATION. |
| Routes of Entry | Absorbed through skin. Dermal contact. Eye contact. Inhalation. Ingestion. |
| Potential Acute Health Effects |
| Eyes | Hazardous in case of eye contact (irritant). Inflammation of the eye is characterized by redness, watering, and itching. |
| Skin | Hazardous in case of skin contact (permeator, irritant). Skin inflammation is characterized by itching, scaling, reddening, or, occasionally, blistering. |
| Inhalation | Hazardous in case of inhalation (lung irritant). |
| Ingestion | Hazardous in case of ingestion. |
| Potential Chronic Health Effects |
| Carcinogenic Effects | Classified 3 by IARC (Sodium Cyclamate) |
| Additional information See Toxicological Information (section 11) |
| Medical Conditions Aggravated by Overexposure: | Repeated exposure to a highly toxic material may produce general deterioration of health by an accumulation in one or many human organs. |
| Section 4. First Aid Measures |
| Eye Contact | Check for and remove any contact lenses. In case of contact, immediately flush eyes with plenty of water for at least 15 minutes. Cold water may be used. Get medical attention immediately. |
| Skin Contact | In case of contact, immediately flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Cover the irritated skin with an emollient. Cold water may be used. Wash clothing before reuse. Thoroughly clean shoes before reuse. Get medical attention immediately. |
| Inhalation | If inhaled, remove to fresh air. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical attention immediately. |
| Ingestion | If swallowed, do not induce vomiting unless directed to do so by medical personnel. Never give anything by mouth to an unconscious person. Loosen tight clothing such as a collar, tie, belt or waistband. Get medical attention immediately. |
| Section 5. Fire Fighting Measures |
| Flammability of the Product | Non-flammable. |
| Auto-ignition Temperature | Not applicable. |
| Flash Points | Not applicable. |
| Flammable Limits | Not applicable. |
| Products of Combustion | Not available. |
| Fire Hazards in Presence of Various Substances | Not applicable. |
| Explosion Hazards in Presence of Various Substances | Risks of explosion of the product in presence of static discharge: No.
Risks of explosion of the product in presence of mechanical impact: No. |
| Fire Fighting Media
and Instructions |
Not applicable. |
| Protective Clothing (Fire) | Not applicable. |
| Special Remarks on Fire Hazards | Not available. |
| Special Remarks on Explosion Hazards | Not available. |
| Section 6. Accidental Release Measures |
| Small Spill and Leak | Use appropriate tools to put the spilled solid in a convenient waste disposal container. |
| Large Spill and Leak | Stop leak if without risk. Do not get water inside container. Do not touch spilled material. Use water spray to reduce vapors. Prevent entry into sewers, basements or confined areas; dike if needed. Call for assistance on disposal. Finish cleaning by spreading water on the contaminated surface and allow to evacuate through the sanitary system. |
| Spill Kit Information | No specific spill kit required for this product. |
| Section 7. Handling and Storage |
| Handling | Do not ingest. Avoid breathing dust. Keep container closed. Do not get in eyes, on skin, or on clothing. |
| Storage | Store frozen. Warm to room temperature before opening. |
| Section 8. Exposure Controls/Personal Protection |
| Engineering Controls | Use process enclosures, local exhaust ventilation, or other engineering controls to keep airborne levels below recommended exposure limits. If user operations generate dust, fume or mist, use ventilation to keep exposure to airborne contaminants below the exposure limit. |
| Personal Protection |
| Eyes | Splash goggles. |
| Body | Lab coat. |
| Respiratory | Dust respirator. Be sure to use an approved/certified respirator or equivalent. Wear appropriate respirator when ventilation is inadequate. |
| Hands | Gloves. |
| Feet | Not applicable. |
|
|
| Personal Protection in Case of a Large Spill | Splash goggles. Full suit. Dust respirator. Boots. Gloves. A self-contained breathing apparatus should be used to avoid inhalation of the product. Suggested protective clothing might not be sufficient; consult a specialist BEFORE handling this product. |
| Product Name | Exposure Limits |
| L(+) Tartaric Acid | Not available. |
| Sodium Cyclamate | Not available. |
| L-Leucine | Not available. |
| 1,2-Phenylenediamine Dihydrochloride | Not available. |
| Sodium Carbonate, Anhydrous | Not available. |
| Section 9. Physical and Chemical Properties |
| Odor | Not available. |
| Color | Not available. |
| Physical State and Appearance | Solid. (Tablet) |
| Molecular Weight | Not applicable. |
| Molecular Formula | Not applicable. |
| pH | Not available. |
| Boiling/Condensation Point | Not available. |
| Melting/Freezing Point | 851.06°C (1563.9°F) based on data for: Sodium Carbonate, Anhydrous. Weighted average: 394.11°C (741.4°F) |
| Specific Gravity | Not available. |
| Vapor Pressure | Not available. |
| Vapor Density | Not available. |
| Odor Threshold | Not available. |
| Evaporation Rate | Not available. |
| LogKow | Not available. |
| Solubility | Easily soluble in water. |
| Section 10. Stability and Reactivity |
| Stability and Reactivity | The product is stable. |
| Conditions of Instability | Not available. |
| Incompatibility with Various Substances | Reactive with acids. |
| Rem/Incompatibility | Not available. |
| Hazardous Decomposition Products | These products are halogenated compounds. |
| Hazardous Polymerization | Will not occur. |
| Section 11. Toxicological Information |
| RTECS Number: |
| L(+) Tartaric Acid | WW7875000 |
| Sodium Cyclamate | GV7350000 |
| L-Leucine | OH2850000 |
| 1,2-Phenylenediamine Dihydrochloride | ST0175000 |
| Sodium Carbonate | VZ4050000 |
| Toxicity | Acute oral toxicity (LD50): 1280 mg/kg [Rat]. (Sodium Cyclamate).
Acute toxicity of the vapor (LC50): 800 mg/m3 2 hour(s) [Guinea pig]. (Sodium Carbonate, Anhydrous). |
| Chronic Effects on Humans | Not available. |
| Acute Effects on Humans | Hazardous in case of eye contact (irritant). Inflammation of the eye is characterized by redness, watering, and itching. Hazardous in case of skin contact (permeator, irritant). Skin inflammation is characterized by itching, scaling, reddening, or, occasionally, blistering. Hazardous in case of inhalation (lung irritant). Hazardous in case of ingestion. |
| Synergetic Products (Toxicologically) | Not available. |
| Irritancy | Draize Test: Not available. |
| Sensitization | Hazardous in case of skin contact (sensitizer). |
| Carcinogenic Effects | Classified 3 by IARC (Sodium Cyclamate) |
| Toxicity to Reproductive System | Not available. |
| Teratogenic Effects | Not available. |
| Mutagenic Effects | Not available. |
| Section 12. Ecological Information |
| Ecotoxicity | Not available. |
| BOD5 and COD | Not available. |
| Toxicity of the Products of Biodegradation | The products of degradation are as toxic as the product itself. |
| Section 13. Disposal Considerations |
| EPA Waste Number | Not available. |
| Treatment | Material does not have an EPA Waste Number and is not a listed waste, however consultation with a permitted waste disposal site (TSD) should be accomplished. Always contact a permitted waste disposal (TSD) to assure compliance with all current local, state, and Federal Regulations.. |
| Section 14. Transport Information |
| DOT Classification | Not available. |
| TDG Classification | Not available. |
| IMO/IMDG Classification | Not available. |
| ICAO/IATA Classification | Not available. |
| Section 15. Regulatory Information |
| U.S. Federal Regulations | TSCA 8(b) inventory: L(+) Tartaric Acid; Sodium Cyclamate; L-Leucine; 1,2-Phenylenediamine Dihydrochloride; Sodium Carbonate, Anhydrous
TSCA 8(d) H and S data reporting: 1,2-Phenylenediamine Dihydrochloride: 1983 |
| SARA 302/304/311/312 extremely hazardous substances: No products were found.
SARA 302/304 emergency planning and notification: No products were found. SARA 302/304/311/312 hazardous chemicals: Sodium Cyclamate; Sodium Carbonate, Anhydrous SARA 311/312 MSDS distribution - chemical inventory - hazard identification: Sodium Cyclamate: Delayed (Chronic) Health Hazard; Sodium Carbonate, Anhydrous: Immediate (Acute) Health Hazard, Delayed (Chronic) Health Hazard |
| SARA 313 toxic chemical notification and release reporting: 1,2-Phenylenediamine Dihydrochloride 8% |
| Clean Water Act (CWA) 307: No products were found. |
| Clean Water Act (CWA) 311: No products were found. |
| Clean air act (CAA) 112 accidental release prevention: No products were found. |
| Clean air act (CAA) 112 regulated flammable substances: No products were found. |
| Clean air act (CAA) 112 regulated toxic substances: No products were found. |
| WHMIS (Canada) | Class D-1A: Material causing immediate and serious toxic effects (VERY TOXIC).
Class D-2B: Material causing other toxic effects (TOXIC). |
| CEPA DSL: L(+) Tartaric Acid; Sodium Cyclamate; L-Leucine; 1,2-Phenylenediamine Dihydrochloride; Sodium Carbonate, Anhydrous |
| This product has been classifed in accordance with the hazard criteria of the Controlled Product Regulations and the MSDS contains all required information. |
| International Regulations |
| EINECS | L(+) Tartaric Acid 201-766-0
Sodium Cyclamate 205-348-9 L-Leucine 200-522-0 1,2-Phenylenediamine Dihydrochloride 210-418-7 Sodium Carbonate, Anhydrous 207-838-8 |
| DSCL (EEC) | R22- Harmful if swallowed.
R37/38- Irritating to respiratory system and skin. R41- Risk of serious damage to eyes. R43- May cause sensitization by skin contact. |
| International Lists | Australia (NICNAS): L(+) Tartaric Acid; Sodium Cyclamate; L-Leucine; 1,2-Phenylenediamine Dihydrochloride; Sodium Carbonate, Anhydrous
China: Sodium Cyclamate Japan (MITI): L(+) Tartaric Acid; Sodium Cyclamate; L-Leucine; 1,2-Phenylenediamine Dihydrochloride; Sodium Carbonate, Anhydrous Korea (TCCL): L(+) Tartaric Acid; 1,2-Phenylenediamine Dihydrochloride; Sodium Carbonate, Anhydrous Philippines (RA6969): L(+) Tartaric Acid; Sodium Cyclamate; L-Leucine; Sodium Carbonate, Anhydrous |
| China: Sodium Cyclamate |
| State Regulations | No products were found. |
| California prop. 65: No products were found. |
| Section 16. Other Information |
|
|
|
| Changed Since Last Revision | + |
| Notice to Reader |
| The statements contained herein are based upon technical data that EMD Chemicals Inc. believes to be reliable, are offered for information purposes only and as a guide to the appropriate precautionary and emergency handling of the material by a properly trained person having the necessary technical skills. Users should consider these data only as a supplement to other information gathered by them and must make independent determinations of suitability and completeness of information from all sources to assure proper use, storage and disposal of these materials and the safety and health of employees and customers and the protection of the environment. EMD CHEMICALS INC. MAKES NO REPRESENTATION OR WARRANTY OF ANY KIND, EXPRESS OR IMPLIED, INCLUDING MERCHANTABILITY OR FITNESS FOR A PARTICULAR USE, WITH RESPECT TO THE INFORMATION HEREIN OR THE PRODUCT TO WHICH THE INFORMATION REFERS. |
